Über diesen Podcast

Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.

956 Folgen · Geneeskunde

NEJM Interviews

Von NEJM Group

In Spotify hörenFunktioniert auch im Browser

Apple PodcastsÖffnen
Pocket CastsÖffnen
Amazon MusicÖffnen
DeezerÖffnen
OvercastÖffnen

11 weitere Apps

Player FMÖffnen
CastroÖffnen
Podcast AddictÖffnen
YouTubeÖffnen
CastboxÖffnen
Podcast RepublicÖffnen
AntennaPodÖffnen
iHeartRadioÖffnen
TuneInÖffnen
FountainÖffnen

Neueste FolgeNEJM Interview: Anjali Deshmukh on legal challenges to fines issued by federal agencies.vor 3 Tagen14 Min.

Über diesen Podcast

Neue Folgen

NEJM Interview: Matthew Vogel on the emergence of clinical trial prediction markets.21. Okt. · 7 Min.
NEJM Interview: Lena Makaroun on opportunities for clinicians to address firearm-related risks with their older patients.14. Okt. · 14 Min.
NEJM Interview: Sarah Schmitz on protections for people enrolled in trials of investigational agents for obesity.7. Okt. · 6 Min.
NEJM Interview: Benjamin Scher on opioid litigation and governance systems for spending related funds.30. Sept. · 9 Min.
NEJM Interview: Christopher Forrest on declines in the health of U.S. children and the role of communities in reversing those trends.23. Sept. · 13 Min.
NEJM Interview: Dhruv Khullar on concerns about displacement of clinicians by artificial intelligence and counterarguments based on economic theory.16. Sept. · 9 Min.
NEJM Interview: Elizabeth Kaplan on changes to the U.S. Preventive Services Task Force and the importance of evidence-based recommendations for preventive services.9. Sept. · 12 Min.
NEJM Interview: Elizabeth Tobin-Tyler on the legal argument that permitting telehealth access to mifepristone can abet reproductive coercion.2. Sept. · 12 Min.
NEJM Interview: Rebecca Haffajee on the rescheduling of medical marijuana products and its potential effect on research.19. Aug. · 13 Min.
NEJM Interview: Eric Schneider on the limitations of pay-for-performance programs and alternative options to support quality improvement.12. Aug. · 9 Min.